Skip to main content
eScholarship
Open Access Publications from the University of California

Clinical Experience With an L-Proline-Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability

  • Author(s): Dorsey, Morna
  • Dorsey, MJ
  • Dorsey, MJ
  • Ho, V
  • Mabudian, M
  • Soler-Palacín, P
  • Domínguez-Pinilla, N
  • Rishi, R
  • Rishi, R
  • Wong, D
  • Rojavin, M
  • et al.

Published Web Location

http://europepmc.org/articles/PMC4165870?pdf=render
No data is associated with this publication.
Abstract

Purpose This retrospective study evaluated the effectiveness and tolerability in clinical practice of an L-proline-stabilized 10 % intravenous immunoglobulin (IVIG; Privigen®) in patients with primary (PID) or secondary immunodeficiency (SID). Methods Pati

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item